SHORT MINI-FUTURE - PFIZER INC Share Price

Certificat

DE000VX4VZS2

Delayed Deutsche Boerse AG 08:12:13 21/05/2024 pm IST
3.37 EUR +0.60% Intraday chart for SHORT MINI-FUTURE - PFIZER INC
Current month-9.95%
1 month-9.95%
Date Price Change
21/24/21 3.37 +0.60%
20/24/20 3.35 0.00%
17/24/17 3.35 +0.60%
16/24/16 3.33 0.00%
15/24/15 3.33 -2.06%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 08:12 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VX4VZS
ISINDE000VX4VZS2
Date issued 17/12/2021
Strike 65.07 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.73
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.77
Lowest since issue 0.67
Spread 0.01
Spread %0.29%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.53 USD
Average target price
31.94 USD
Spread / Average Target
+11.95%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW